|
|
Article: Nanobac Pharmaceuticals, Inc. Announces Southern Medical Journal Publication of Nanobacteria Caused Mitral Valve Calciphylaxis.
- Article from:
- Business Wire
- Article date:
- March 11, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
TAMPA, Fla.--(BUSINESS WIRE)--March 11, 2004
Nanobac Pharmaceuticals, Inc. (OTCPK:NNBP) ("Nanobac" or "The Company"), announces the publication of independent research which reports that Nanobacteria caused mitral valve calciphylaxis in a man with diabetic renal failure. Dr. Jelic et. al., Department of Pathology, Memorial Hospital, Charleston Area Medical Center, reported in Southern Medical Journal (Volume 97, Number 2, February 2004), the peer reviewed journal of the Southern Medical Association, that Nanobacteria can cause diseases in humans outside the urinary tract. This independent research builds upon the ...